SCHEMBL6334770

SCHEMBL6334770

CC(C)(Sc1ccc(-c2nc(C(=O)Nc3ccc(F)cc3)c(-c3ccc(Cl)cc3)s2)cc1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 1/20 0.43
▸ MAPT P10636 4/20 0.41
▸ PTGS2 P35354 1/20 0.40
▸ PPARG P37231 2/20 0.40
▸ PPARA Q07869 2/20 0.40
▸ HIPK4 Q8NE63 3/20 0.40
▸ PPARD Q03181 1/20 0.40
▸ NPY1R P25929 1/20 0.39
▸ NPY2R P49146 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ TBXA2R P21731 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326299 0.95 XDH (0.47) XDHMAPTPPARGPPARAPPARD
SCHEMBL6328143 0.93 PPARG (0.47) XDHMAPTPPARGPPARAPPARD
SCHEMBL6329108 0.92 HIPK4 (0.40) MAPTPPARGPPARAHIPK4PPARD
SCHEMBL6335297 0.92 XDH (0.46) XDHMAPTPPARGPPARAPPARD
SCHEMBL6334499 0.91 PPARA (0.47) XDHMAPTPPARGPPARAPPARD
SCHEMBL6335247 0.90 PPARA (0.43) XDHMAPTPPARGPPARAPPARD
SCHEMBL6328035 0.89 ALOX5 (0.47) XDHMAPTPPARGPPARAPPARD
SCHEMBL6327399 0.89 ALOX5 (0.47) XDHMAPTPPARGPPARAPPARD
SCHEMBL6326381 0.89 TP53 (0.45) MAPTPTGS2PPARGPPARAHIPK4
SCHEMBL6336404 0.88 MAPT (0.42) XDHMAPTPPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION 2005-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity GPR119, EGLN3, PC XDH 1492/4885MAPT 3022/4885PTGS2 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback